Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with ω̄-3 fatty acids and antioxidants

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2576-2588

  Brude, Ingeborg R ^a   Drevon, Christian A ^a   Hjermann, Ingvar ^a   Seljeflot, Ingebjørg ^a   Lund Katz, Sissel ^c   Saarem, Kristin ^a,b   Sandstad, Berit ^a   Solvoll, Kari ^a   Halvorsen, Bente ^a   Arnesen, Harald ^a   Nenseter, Marit S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Petter Möller Orkla ASA   (Norway)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidants; Human mononuclear cells; Hyperlipidemia; Oxidized LDL; 3 fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COPPER ION; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PLACEBO; UBIDECARENONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SURFACE CHARGE;

EID: 17344370607     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2576     Document Type: Article

References (20)

1. Bang HO, Dyerberg J. Lipid metabolism in Greenland Eskimos. In: Draper HH, ed. Advances in Nutrition Research. New York, NY: Plenum Press; 1980;3:1-22.
2. Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Kamugai A, Jajiki J. Eicosapentaenoic acid and platelet function in Japanese. Lancet. 1980;2:1132-1133.
3. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med. 1988;318:549-557.
4. Drevon CA, Nenseter MS, Brude IR, Finstad HS, Kolset SO, Rustan AC. Omega-3 fatty acids: nutritional aspects. Can J Cardiol. 1995;11:47G-54G.
5. Witztum JL. Hypercholesterolemia, hypocholesterolemia, hypertriglyceridemia. In: Malmendier CL, ed. Hypercholesterolemia, Hypocholesterolemia, Hypertriglyceridemia. New York, NY: Plenum Press; 1990:353-365.
6. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
7. Harats D, Dabach Y, Hollander G, Ben-Naim M, Schwartz R, Berry EM, Stein O, Stein Y. Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. Atherosclerosis. 1991;90:127-139.
8. Harris WS, Windsor SL, Caspermeyer JJ. Modification of lipid-related atherosclerosis risk factors by n-3 fatty acid ethyl esters in hypertriglyceridemic patients. J Nutr Biochem. 1993;4:706-712.
9. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, Leboeuf N, Boulet L, de Langavant GC, Davignon J, Naruszewicz M. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb. 1993;13:1790-1797.
10. Oostenbrug GS, Mensink RP, Hornstra G. Effects of fish oil and , vitamin E supplementation on copper-catalysed oxidation of human low density lipoprotein in vitro. Eur J Clin Nutr. 1994;48:895-898.
11. Suzukawa M, Abbey M, Howe PR, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res. 1995;36:473-484.
12. Nenseter MS, Rustan AC, Lund-Katz S, Soyland E, Maelandsmo G, Phillips MC, Drevon CA. Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans. Arterioscler Thromb. 1992;12:369-379.
13. Nenseter MS, Rustan AC, Lund-Katz S, Søyland E, Drevon CA. 1993. Dietary supplementation with n-3 and n-6 polyunsaturated fatty acids in humans: effects on chemical composition, cellular metabolism and susceptibility of low density lipoprotein to lipid peroxidation. In: Drevon CA, Baksaas I, Krokan HE, eds. Omega-3 Fatty Acids. Basel, Switzerland: Birkhäuser Verlag/Switzerland; 1993:41-49.
14. Bittolo-Bon G, Cazzolato G, Alessandrini P, Soldan S, Casalino G, Avogaro P. Effects of concentrated DHA and EPA supplementation on LDL peroxidation and vitamin E status in type HB hyperlipidemic patients. In: Drevon CA, Baksaas I, Krokan HE, eds. Omega-3 Fatty Acids. Basel, Switzerland: Birkhauser Verlag/ Switzerland; 1993:51-58.
15. Frankel EN, Parks EJ, Xu R, Schneeman BO, Davis PA, German JB. Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins. Lipids. 1994;29:233-236.
16. Bonanome A, Biasia F, De Luca M, Munaretto G, Biffanti S, Pradella M, Pagnan A. n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr. 1996;63:261-266.
17. Wander RC, Du SH, Ketchum SO, Rowe KE. Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy. Am J Clin Nutr. 1996;63:184-193.
18. 2(+)-catalyzed-oxidative modification. Biochem Biophys Res Commun. 1991;175:61-67.
19. Thomas MJ, Thornburg T, Manning J, Hooper K, Rudel LL. Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry. 1994;33:1828-1834.
20. Whitman SC, Fish JR, Rand ML, Rogers KA. n-3 Fatty acid incorporation into LDL particles renders them more susceptible to oxidation in vitro but not necessarily more atherogenic in vivo. Arterioscler Thromb. 1994;14:1170-1176.